A detailed history of Globalt Investments LLC / Ga transactions in Eli Lilly & CO stock. As of the latest transaction made, Globalt Investments LLC / Ga holds 21,076 shares of LLY stock, worth $18.7 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
21,076
Previous 21,468 1.83%
Holding current value
$18.7 Million
Previous $16.7 Billion 14.25%
% of portfolio
0.76%
Previous 0.66%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $284,149 - $356,343
-392 Reduced 1.83%
21,076 $19.1 Billion
Q1 2024

May 01, 2024

SELL
$592.2 - $792.28 $796,509 - $1.07 Million
-1,345 Reduced 5.9%
21,468 $16.7 Billion
Q4 2023

Feb 20, 2024

BUY
$525.19 - $619.13 $12 Million - $14.1 Million
22,813 New
22,813 $13.3 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Globalt Investments LLC / Ga Portfolio

Follow Globalt Investments LLC / Ga and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globalt Investments LLC / Ga, based on Form 13F filings with the SEC.

News

Stay updated on Globalt Investments LLC / Ga with notifications on news.